Inherited and acquired disorders of mitochondrial DNA;Hereditäre und erworbene Störungen mitochondrialer DNA

Praxis

Volumn 91, Issue 49, 2002, Pages 2129-2138

  Walker, U A ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cardiomyopathy; Diabetes mellitus; Encephalopathy; HIV; Lipodystrophy; Mitochondria; Mitochondrial DNA; Myopathy; Nucleoside analogues

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CARNITINE; MITOCHONDRIAL DNA; SCAVENGER; VITAMIN;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY; CHILD; COMPARATIVE STUDY; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; LIPODYSTROPHY; MALE; MIDDLE AGED; MITOCHONDRIAL MYOPATHY; MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; POINT MUTATION; REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-HIV AGENTS; CARDIOMYOPATHIES; CARNITINE; CHILD; DIABETES MELLITUS; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; FEMALE; FREE RADICAL SCAVENGERS; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; LIPODYSTROPHY; MALE; MIDDLE AGED; MITOCHONDRIAL DISEASES; MITOCHONDRIAL MYOPATHIES; MUTATION; PHENOTYPE; POINT MUTATION; VITAMINS;

EID: 17144437540     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.91.49.2129     Document Type: Review

References (70)

1. Luft R., Ikkos D., Palmieri G., Ernster L., Afzelius B.: A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J. Clin. Invest. 41, 1776-1804, 1962.
2. Anderson S., Bankier A.T., Barell B.G., de Bruijn M.H.L., Coulson A.R., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., et al.: Sequence and organization of the human mitochondrial genome. Nature 9, 457-465, 1981. (Pubitemid 11159074)
3. Wallace D.C., Singh G., Lott M.T.: Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242, 1427-1430, 1988. (Pubitemid 19008070)
4. Nishino I., Spinazzola A., Hirano M.: Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283, 689-692, 1999.
5. Wallace D.C.: Mitochondrial diseases in man and mouse. Science 283, 1482-1488, 1999.
6. Naviaux R.K., Nyhan W.L., Barshop B.A., Poulton J., Markusic D., Karpinski N.C., Haas R.H.: Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome. Ann. Neurol. 45, 54-58, 1999. (Pubitemid 29036432)
7. Papadopoulou L.C., Sue C.M., Davidson M.M., Tanji K., Nishino I., Sadlock J.E., Krishna S., Walker W., Selby J., et al.: Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat. Genet. 23, 333-337, 1999. (Pubitemid 29526433)
8. Sue C.M., Karadimas C., Checcarelli N., Tanji K., Papadopoulou L.C., Pallotti F., Guo F.L., Shanske S., Hirano M., et al.: Differential features of patients with mutations in two COX assembly genes, SURF-1 and SCO2. Ann. Neurol. 47, 589-595, 2000. (Pubitemid 30261894)
9. Chinnery P.F., Johnson M.A., Wardell T.M., Singh-Kler R., Hayes C., Brown D.T., Taylor R.W., Bindoff L.A., Turnbull D.M.: The epidemiology of pathogenic mitochondrial DNA mutations. Ann. Neurol. 48, 188-193, 2000. (Pubitemid 30617037)
10. Darin N., Oldfors A., Moslemi A.R., Holme E., Tulinius M.: The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities. Ann. Neurol. 49, 377-383, 2001. (Pubitemid 32202792)
11. Majamaa K., Moilanen J.S., Uimonen S., Remes A.M., Salmela P.I., Karppa M, Majamaa- Voltti KA, Rusanen H, Sorri M, et al: Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am. J. Hum. Genet. 63, 447-454, 1998. (Pubitemid 30418626)
12. Makino M., Horai S., Goto Y., Nonaka I.: Mitochondrial DNA mutations in Leigh syndrome and their phylogenetic implications. Journal of Human Genetics 45, 69-75, 2000. (Pubitemid 30146055)
13. Rotig A., Bourgeron T., Chretien D., Rustin P., Munnich A.: Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum. Mol. Genet. 4, 1327-1330, 1995.
14. Mojon D.: Eye diseases in mitochondrial encephalomyopathies. Therapeutische Umschau 58, 49-55, 2001.
15. Chalmers R.M., Schapira A.H.: Clinical, biochemical and molecular genetic features of Leber's hereditary optic neuropathy. Biochim. Biophys. Acta. 1410, 147-158, 1999. (Pubitemid 29078601)
16. Majamaa K., Turkka J., Karppa M., Winqvist S., Hassinen I.E.: The common MELAS mutation a3243g in mitochondrial DNA among young patients with an occipital brain infarct. Neurology 49, 1331-1334, 1997. (Pubitemid 27495638)
17. Holt I.J., Harding A.E., Petty R.K., Morgan H.J.A.: A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 46, 428-433, 1990.
18. Vu T.H., Sciacco M., Tanji K., Nichter C., Bonilla E., Chatkupt S., Maertens P., Shanske S., Mendell J., et al.: Clinical manifestations of mitochondrial DNA depletion. Neurology 50, 1783-1790, 1998. (Pubitemid 28283252)
19. Jaksch-Angerer M., Hofmann S., Bauer M.F., Gempel K, Obermaier- Kusser B, Paetzke I, Gerbitz K-D: Mitochondriale Erkrankungen Biochemisch- molekularbiologische Diagnostik von Defekten der Atmungskette. Dt Ärztebl 96, A-2971-81, 1999.
20. Turner L.F., Kaddoura S., Harrington D., Cooper J.M., Poole-Wilson P.A., Schapira A.H.: Mitochondrial DNA in idiopathic cardiomyopathy. Europ. Heart. J. 19, 1725-1729, 1998. (Pubitemid 28524193)
21. Maassen J.A., van den Ouweland J.M., 't Hart L.M., Lemkes H.H.: Maternally inherited diabetes and deafness: a diabetic subtype associated with a mutation in mitochondrial DNA. Horm. Metab. Res. 29, 50-55, 1997. (Pubitemid 27170090)
22. Gerbitz K.D., van den Ouweland J.M., Maassen J.A., Jaksch M.: Mitochondrial diabetes mellitus: a review. Biochim. Biophys. Acta. 1271, 253-260, 1995.
23. Kadowaki T., Sakura H., Otabe S., Yasuda K., Kadowaki H., Mori Y., Hagura R., Akanuma Y., Yazaki Y.: A subtype of diabetes mellitus associated with a mutation in the mitochondrial gene. Muscle Nerve 3, S137-S141, 1995.
24. Olsson C., Zethelius B., Lagerstrom-Fermer M., Asplund J., Berne C., Landegren U.: Level of heteroplasmy for the mitochondrial mutation A3243G correlates with age at onset of diabetes and deafness. Hum. Mutat. 12, 52-58, 1998. (Pubitemid 28262225)
25. Yamagata K., Tomida C., Umeyama K., Urakami K., Ishizu T., Hirayama K., Gotoh M., Iitsuka T., Takemura K., et al.: Prevalence of Japanese dialysis patients with an A-to-G mutation at nucleotide 3243 of the mitochondrial tRNA(Leu(UUR)) gene. Nephrol. Dial. Transplant. 15, 385-388, 2000. (Pubitemid 30116474)
26. Newkirk J.E., Taylor R.W., Howell N., Bindoff L.A., Chinnery P.F., Alberti K.G., Turnbull D.M., Walker M.: Maternally inherited diabetes and deafness: prevalence in a hospital diabetic population. Diabet. Med. 14, 457-460, 1997. (Pubitemid 27286516)
27. Kameoka K., Isotani H., Tanaka K., Azukari K., Fujimura Y., Shiota Y., Sasaki E., Majima M., Furukawa K., et al.: Novel mitochondrial DNA mutation in tRNA (Lys) (8296AÆG) associated with diabetes. Biochem. Biophys. Res. Commun. 245, 523-527, 1998. (Pubitemid 28418538)
28. Gomez-Zaera M., Strom T.M., Rodriguez B., Estivill X., Meitinger T., Nunes V.: Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees. Molecular Genetics & Metabolism 72, 72-81, 2001. (Pubitemid 34169354)
29. Chinnery P.F., Turnbull D.M.: Mitochondrial Medicine. Q. J. Med. 90, 657-667, 1997. (Pubitemid 27483426)
30. St. John J.C., Cooke I.D., Barratt C.L.: Mitochondrial mutations and male infertility. Nature Med. 3, 124-125, 1997.
31. Klopstock T., Naumann M., Seibel P., Shalke B., Reiners K., Reichmann H.: Mitochondrial DNA mutations in multiple symmetric lipomatosis. Mol. Cell. Biochem. 174, 271-275, 1997. (Pubitemid 27404202)
32. Silvestri G., Ciafaloni E., Santorelli F., Shanske S., Servidei S., Graf W.D., Sumi M., DiMauro S., Santorelli F.M.: Clinical features associated with the A to G transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology 43, 1200-1206, 1993. (Pubitemid 23177724)
33. Niaudet P., Rötig A.: The kidney in mitochondrial cytopathies. Kidney Int. 51, 1000-1007, 1997. (Pubitemid 27186523)
34. Shoffner J.M., Voljavec A.S., Dixon J., Kaufman A., Wallace D.C., Mitch W.E.: Renal amino acid transport in adults with oxidative phosphorylation diseases. Kidney Int. 47, 1101-1107, 1995.
35. Cheong H.I., Chae J.H., Kim J.S., Park H.W., Ha I.S., Hwang Y.S., Lee H.S., Choi Y.: Hereditary glomerulopathy associated with a mitochondrial tRNA(Leu) gene mutation. Pediatr. Nephrol. 13, 477-480, 1999. (Pubitemid 29348700)
36. Sue C.M., Tanji K., Hadjigeorgiou G., Andreu A.L., Nishino I., Krishna S., Bruno C., Hirano M., Shanske S., et al.: Maternally inherited hearing loss in a large kindred with a novel T7511C mutation in the mitochondrial dna tRNA(Ser(ucn)) gene. Neurology 52, 1905-1908, 1999. (Pubitemid 29260910)
37. Tamagawa Y., Kitamura K., Hagiwara H., Ishida T., Nishizawa M., Saito T., Iwamoto Y.: Audiologic findings in patients with a point mutation at nucleotide 3,243 of mitochondrial DNA. Ann. Otol. Rhinol. Laryngol. 106, 338-342, 1997. (Pubitemid 27175025)
38. Casano R.A., Johnson D.F., Bykhovskaya Y., Torricelli F., Bigozzi M., Fischel- Ghodsian N.: Inherited susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinical implications. Am. J. Otolaryngol. 20, 151-156, 1999. (Pubitemid 29196560)
39. Bykhovskaya Y., Estivill X., Taylor K., Hang T., Hamon M., Casano R.A., Yang H., Rotter J.I., Shohat M., et al.: Candidate locus for a nuclear modifier gene for maternally inherited deafness. Am. J. Hum. Genet. 66, 1905-1910, 2000. (Pubitemid 30480097)
40. Hofhaus G., Gattermann N.: Mitochondria harbouring mutant mtDNA - a cuckoo in the nest? Biol. Chem. 380, 871-877, 1999. (Pubitemid 29412744)
41. Cormier-Daire V., Bonnefont J.P., Rustin P., Maurage C., Ogler H., Schmitz J., Ricour C., Saudubray J.M., Munnich A., et al.: Mitochondrial DNA rearrangements with onset as chronic diarrhea with villous atrophy. J. Pediatr. 124, 63-70, 1994. (Pubitemid 24027288)
42. Hirano M., Silvestri G., Blake D.M., Lombes A., Minetti C., Bonilla E., Hays A.P., Lovelace R.E., Butler I., et al.: Mitochondrial neurogastrointestinal encephalomyopahty (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44, 721-727, 1994. (Pubitemid 24130006)
43. Nishino I., Spinazzola A., Papadimitriou A., Hammans S., Steiner I., Hahn C.D., Connolly A.M., Verloes A., Guimaraes J., et al.: Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann. Neurol. 47, 792-800, 2000. (Pubitemid 30390200)
44. Hattori K., Tanaka M., Sugiyama S., Obayashi T., Ito T., Satake T., Hanaki Y., Asai J., Nagano M., et al.: Age-dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. Am. Heart. J. 121, 1735-1742, 1991.
45. Müller-Höcker J.: Cytochrome-c-oxidase deficient cardiomyocytes in the human heart - an age-related phenomenon. Am. J. Pathol. 134, 1167-1173, 1989.
46. Corral-Debrinski M., Stepien G., Shoffner J.M., Lott M.T., Kanter K., Wallace D.C.: Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. JAMA 266, 1812-1816, 1991.
47. Fromenty B., Pessayre D.: Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther. 67, 101-154, 1995.
48. Mansouri A., Fromenty B., Berson A., Robin M.A., Grimbert S., Beaugrand M., Erlinger S., Pessayre D.: Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. J. Hepatol. 27, 96-102, 1997. (Pubitemid 27357061)
49. Mansouri A., Demeilliers C., Amsellem S., Pessayre D., Fromenty B.: Acute ethanol administration oxidatively damages and depletes mitochondrial DNA in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants. J. Pharmacol. Exp. Ther. 298, 737-743, 2001. (Pubitemid 32673427)
50. Di Cataldo A., Palumbo M., Pittala D., Renis M., Schiliro G., Russo A., Ragusa R., Mollica F., Li Volti S.: Deletions in the mitochondrial DNA and decrease in the oxidative phosphorylation activity of Children with Fanconi syndrome secondary to antiblastic therapy. Am. J. Kidney Dis. 34, 98-106, 1999. (Pubitemid 29318802)
51. Singh K.K., Russell J., Sigala B., Zhang Y., Williams J., Keshav K.F.: Mitochondrial DNA determines the cellular response to cancer therapeutic agents. Oncogene 18, 6641-6646, 1999.
52. Fliss M.S., Usadel H., Caballero O.L., Wu L., Buta M.R., Eleff S.M., Jen J., Sidransky D.: Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287, 2017-2019, 2000. (Pubitemid 30158678)
53. Coller H.A., Khrapko K., Bodyak N.D., Nekhaeva E., Herrero-Jimenez P., Thilly W.G.: High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nature Genet. 28, 147-150, 2001. (Pubitemid 32538059)
54. Brinkman K., ter Hofstede H.J., Burger D.M., Smeitink J.A., Koopmans P.P.: Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 12, 1735-1744, 1998. (Pubitemid 28454438)
55. Arnaudo E., Dalakas M., Shanske S., Moraes C.T., DiMauro S., Schon E.A.: Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine- induced myopathy. Lancet 337, 508-510, 1991.
56. Miller K.D., Cameron M., Wood L.V., Dalakas M.C., Kovacs J.: Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. Ann. Intern. Med. 133, 192-196, 2000. (Pubitemid 30617057)
57. Chariot P., Drogou I., de Lacroix-Szmania I., Eliezer-Vanerot M.C., Chazaud B., Lombes A., Schaeffer A., Zafrani E.S.: Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J. Hepatol. 30, 156-160, 1999. (Pubitemid 29023665)
58. John M., Moore C.B., James I.R., Nolan D., Upton R.P., McKinnon E.J., Mallal S.A.: Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy. AIDS 15, 717-723, 2001. (Pubitemid 32423219)
59. Gerard Y., Maulin L., Yazdanpanah Y., Tribonniere X., Amiel C., Maurage C.A., Robin S., Sablonniere B., Dhennain C.,et al.: Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy. AIDS 14, 2723-2730, 2000. (Pubitemid 32118726)
60. Walker U.A., Bickel M., Lütke Volksbeck S.I., Schöfer H., Setzer B., Venhoff N., Rickerts V., Staszewski S.: Evidence of nucleoside analogue reverse transcriptase inhibitor-associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients. JAIDS 29, 117-121, 2001. (Pubitemid 34164881)
61. Walker U.A., Bickel M., Lütke Volksbeck S.I., Schöfer H., Setzer B., Rickerts V., Staszewski S.: Decrease of mitochondrial DNA content in adipose tissue of HIV-1 infected patients treated with NRTIs. Antivir Ther. 5, Suppl 5, 5-6, 2000.
62. Honkoop P., de Man R.A., Scholte H.R., Zondervan P.E., Van Den Berg J.W., Rademakers L.H., Schalm S.W.: Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B. Hepatology. 26, 211-215, 1997. (Pubitemid 27280327)
63. Tanji N., Tanji K., Kambham N., Markowitz G.S., Bell A., D'agati V.D.: Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum. Pathol. 32, 734-740, 2001. (Pubitemid 32726898)
64. Ho E.S., Lin D.C., Mendel D.B., Cihlar T.: Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J. Am. Soc. Nephrol. 11, 383-393, 2000. (Pubitemid 30115068)
65. Walker U.A., Collins S., Byrne E.: Respiratory chain encephalomyopathies: A diagnostic classification. Eur. Neurol. 36, 260-267, 1996. (Pubitemid 26261655)
66. Walker U.A., Byrne E.: The therapy of respiratory chain encephalomyopathy: a critical review of the past and current perspective. Acta. Neurol. Scand. 92, 273-280, 1995.
67. Przyrembel H.: Therapy of mitochondrial disorders. J. Inherited. Metab. Dis. 10, 129-146, 1987.
68. Fromenty B., Pessayre D: Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol 26, Suppl-53, 1997.
69. Kakuda T.N., Brinkman K.: Mitochondrial toxic effects and ribavirin. Lancet 357, 1802-1803, 2001.
70. Brinkman K., Vrouenraets S., Kauffman R., Weigel H., Frissen J.: Treatment of nucleoside reverse transcriptase inhibitor-induced lactic acidosis. AIDS 14, 2801-2802, 2000. (Pubitemid 32118740)